Skip to main content
TipRanks
Go Ultimate75% OFF

Adaptimmune Therapeutics (ADAPY) Q4 2024 Earnings Report

1,249 Followers

ADAPY Q4 2024 EPS Results

Actual EPS
-$0.05
Consensus EPS
-$0.03
Beat/Miss
Missed by -$0.02
One Year Ago EPS
-$0.04

ADAPY Q4 2024 Revenue Results

Actual Revenue
$3.19M
Expected Revenue
$7.84M
Beat/Miss
Missed by -$4.65M
YoY Revenue Growth
+1269.61%

Earnings Announcement Details

Quarter
Q4 2024
Date
03/20/2025
Time
Before Open
Conference Call
Thursday, March 20, 2025

Q4 2024 Earnings Call Audio

ADAPY Q4 2024 Earnings Call
0:00 / 0:00

Q4 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

ADAPY Earnings History

ADAPY earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Aug 12, 20262026 (Q2)―--0.12―
May 20, 20262026 (Q1)-0.03--0.03―
Mar 10, 20262025 (Q4)-0.06-0.03-0.0540.00% (+0.02)
Nov 05, 20252025 (Q3)-0.12--0.01―
Aug 13, 20252025 (Q2)-0.04-0.020.04-150.00% (-0.06)
May 13, 20252025 (Q1)-0.09-0.03-0.030.00% (+0.00)
Mar 20, 20252024 (Q4)-0.03-0.05-0.04-25.00% (-0.01)
Nov 13, 20242024 (Q3)-0.01-0.01-0.0366.67% (+0.02)
Aug 12, 20242024 (Q2)-0.040.04-0.02300.00% (+0.06)
May 15, 20242024 (Q1)-0.15-0.030―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed